05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
Letters of intent, or LOIs, serve an important purpose in corporate deals and M&A, and their use is ...
Read More >
Concrete Contractor Fired Worker after He Complained about Assault, Federal Agency Says - BALTIMO...
Read More >
Recently, the California Supreme Court invalidated a mandatory arbitration agreement in OTO, LLC v. ...
Read More >
Over the last decade, the proliferation of state and local laws regulating employers has exploded. W...
Read More >
Soon after being elected, New Jersey’s Governor created a task force to end misclassification of in...
Read More >
In today’s show, host Tom Fox speaks with Shaina Weisinger of Repurpose House, a company that repur...
Read More >